Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 29 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Συντάκτης is Yavropoulou, Maria P [Clear All Filters]
Effect of intracerebroventricular infusion of insulin on glucose-dependent insulinotropic peptide in dogs..
Neurosci Lett. 460(2), 148-51.
(2009).
(2010).
The incretin effect and secretion in obese and lean women with polycystic ovary syndrome: a pilot study..
J Womens Health (Larchmt). 20(6), 971-6.
(2011). The renin-angiotensin-aldosterone axis in patients with nontumoral [corrected] hyperprolactinemia..
Clin Endocrinol (Oxf). 74(3), 306-11.
(2011). Non tumoral hyperserotoninaemia responsive to octreotide due to dual polymorphism in UGT1A1 and UGT1A6..
Hormones (Athens). 11(1), 104-8.
(2012). Secretory capacity of the parathyroid glands after total thyroidectomy in normocalcemic subjects..
J Clin Endocrinol Metab. 97(7), 2341-6.
(2012). Postprandial response of bone turnover markers in patients with Crohn's disease..
World J Gastroenterol. 20(28), 9534-40.
(2014). Tumor-induced osteomalacia due to a recurrent mesenchymal tumor overexpressing several growth factor receptors..
Endocrinol Diabetes Metab Case Rep. 2015, 150025.
(2015). Expression pattern of the Hedgehog signaling pathway in pituitary adenomas..
Neurosci Lett. 611, 94-100.
(2016).
(2016). Bone Quality Assessment as Measured by Trabecular Bone Score in Patients With End-Stage Renal Disease on Dialysis..
J Clin Densitom. 20(4), 490-497.
(2017). The effect of VPA on bone: From clinical studies to cell cultures-The molecular mechanisms revisited..
Seizure. 48, 36-43.
(2017). Insulin Secretion and Resistance in Normoglycemic Patients with Sickle Cell Disease..
Hemoglobin. 41(1), 6-11.
(2017). Distant lung metastases caused by a histologically benign phosphaturic mesenchymal tumor..
Endocrinol Diabetes Metab Case Rep. 2018,
(2018). Multiple Vertebral Fractures Following Denosumab Discontinuation: Are We Exaggerating?.
Calcif Tissue Int. 103(1), 107-108.
(2018).
(2018). Circulating noggin levels following treatment with denosumab or teriparatide in postmenopausal women with low bone mass..
J Musculoskelet Neuronal Interact. 19(3), 253-257.
(2019). Combination and sequential treatment in women with postmenopausal osteoporosis..
Expert Opin Pharmacother. 21(4), 477-490.
(2020). Circulating microRNAs Related to Bone Metabolism in HIV-Associated Bone Loss..
Biomedicines. 9(4),
(2021).
(2021). Comparative Effect of Zoledronate at 6 Versus 18 Months Following Denosumab Discontinuation..
Calcif Tissue Int.
(2021). The duration of denosumab treatment and the efficacy of zoledronate to preserve bone mineral density after its discontinuation..
J Clin Endocrinol Metab.
(2021). Efficacy of Antiosteoporotic Medications in Patients With Rebound-Associated Fractures After Denosumab Discontinuation..
J Clin Densitom.
(2021). Hypophosphatasia..
J Clin Med. 10(23),
(2021). Postmenopausal osteoporosis coexisting with other metabolic diseases: Treatment considerations..
Maturitas. 147, 19-25.
(2021).